Home  |  Site Map  |  Contact Us  |  
Search

   
   

Our product candidates address medical conditions where we believe there is an unmet need. We currently have three development-stage product candidates. We hold composition-of-matter patents on our product candidates as well as patents or pending patent applications for formulations and methods of synthesis and use.

 

 

 

 

The U.S. National Institutes of Health provides a Web site of many current and past clinical trials. To view information about XenoPort’s clinical trials, please go to
  www.clinicaltrials.gov.